Older adults lack SARS CoV-2 cross-reactive T lymphocytes directed to human coronaviruses OC43 and NL63

Abstract Currently, infections with SARS-Coronavirus-2 (SARS-CoV-2), the causative agent of the COVID-19 pandemic, are responsible for substantial morbidity and mortality worldwide. Older adults subjects > 60 years of age account for > 95% of the over one million fatal cases reported to date....

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Giulietta Saletti, Thomas Gerlach, Janina M. Jansen, Antonia Molle, Husni Elbahesh, Martin Ludlow, Wentao Li, Berend-Jan Bosch, Albert D. M. E. Osterhaus, Guus F. Rimmelzwaan
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2020
Materias:
R
Q
Acceso en línea:https://doaj.org/article/14096393e0f547299e16956eec9932db
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:14096393e0f547299e16956eec9932db
record_format dspace
spelling oai:doaj.org-article:14096393e0f547299e16956eec9932db2021-12-02T16:18:06ZOlder adults lack SARS CoV-2 cross-reactive T lymphocytes directed to human coronaviruses OC43 and NL6310.1038/s41598-020-78506-92045-2322https://doaj.org/article/14096393e0f547299e16956eec9932db2020-12-01T00:00:00Zhttps://doi.org/10.1038/s41598-020-78506-9https://doaj.org/toc/2045-2322Abstract Currently, infections with SARS-Coronavirus-2 (SARS-CoV-2), the causative agent of the COVID-19 pandemic, are responsible for substantial morbidity and mortality worldwide. Older adults subjects > 60 years of age account for > 95% of the over one million fatal cases reported to date. It is unclear why in this age group SARS-CoV-2 infection causes more severe disease than in young adults. We hypothesized that differences in SARS-CoV-2 cross-reactive cellular immunity induced after infection with human coronaviruses (HCoVs), like OC43 and NL63, were at the basis of the differential mortality (and morbidity) observed after SARS-CoV-2 infection, because a small proportion of HCoV-specific T cells cross-react with SARS-CoV-2. Our data demonstrate that pre-existing T cell immunity induced by circulating human alpha- and beta-HCoVs is present in young adult individuals, but virtually absent in older adult subjects. Consequently, the frequency of cross-reactive T cells directed to the novel pandemic SARS-CoV-2 was minimal in most older adults. To the best of our knowledge, this is the first time that the presence of cross-reactive T cells to SARS-CoV-2 is compared in young and older adults. Our findings provide at least a partial explanation for the more severe clinical outcome of SARS-CoV-2 infection observed in the elderly. Moreover, this information could help to design efficacious vaccines for this age group, aiming at the induction of cell-mediated immunity.Giulietta SalettiThomas GerlachJanina M. JansenAntonia MolleHusni ElbaheshMartin LudlowWentao LiBerend-Jan BoschAlbert D. M. E. OsterhausGuus F. RimmelzwaanNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 10, Iss 1, Pp 1-10 (2020)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Giulietta Saletti
Thomas Gerlach
Janina M. Jansen
Antonia Molle
Husni Elbahesh
Martin Ludlow
Wentao Li
Berend-Jan Bosch
Albert D. M. E. Osterhaus
Guus F. Rimmelzwaan
Older adults lack SARS CoV-2 cross-reactive T lymphocytes directed to human coronaviruses OC43 and NL63
description Abstract Currently, infections with SARS-Coronavirus-2 (SARS-CoV-2), the causative agent of the COVID-19 pandemic, are responsible for substantial morbidity and mortality worldwide. Older adults subjects > 60 years of age account for > 95% of the over one million fatal cases reported to date. It is unclear why in this age group SARS-CoV-2 infection causes more severe disease than in young adults. We hypothesized that differences in SARS-CoV-2 cross-reactive cellular immunity induced after infection with human coronaviruses (HCoVs), like OC43 and NL63, were at the basis of the differential mortality (and morbidity) observed after SARS-CoV-2 infection, because a small proportion of HCoV-specific T cells cross-react with SARS-CoV-2. Our data demonstrate that pre-existing T cell immunity induced by circulating human alpha- and beta-HCoVs is present in young adult individuals, but virtually absent in older adult subjects. Consequently, the frequency of cross-reactive T cells directed to the novel pandemic SARS-CoV-2 was minimal in most older adults. To the best of our knowledge, this is the first time that the presence of cross-reactive T cells to SARS-CoV-2 is compared in young and older adults. Our findings provide at least a partial explanation for the more severe clinical outcome of SARS-CoV-2 infection observed in the elderly. Moreover, this information could help to design efficacious vaccines for this age group, aiming at the induction of cell-mediated immunity.
format article
author Giulietta Saletti
Thomas Gerlach
Janina M. Jansen
Antonia Molle
Husni Elbahesh
Martin Ludlow
Wentao Li
Berend-Jan Bosch
Albert D. M. E. Osterhaus
Guus F. Rimmelzwaan
author_facet Giulietta Saletti
Thomas Gerlach
Janina M. Jansen
Antonia Molle
Husni Elbahesh
Martin Ludlow
Wentao Li
Berend-Jan Bosch
Albert D. M. E. Osterhaus
Guus F. Rimmelzwaan
author_sort Giulietta Saletti
title Older adults lack SARS CoV-2 cross-reactive T lymphocytes directed to human coronaviruses OC43 and NL63
title_short Older adults lack SARS CoV-2 cross-reactive T lymphocytes directed to human coronaviruses OC43 and NL63
title_full Older adults lack SARS CoV-2 cross-reactive T lymphocytes directed to human coronaviruses OC43 and NL63
title_fullStr Older adults lack SARS CoV-2 cross-reactive T lymphocytes directed to human coronaviruses OC43 and NL63
title_full_unstemmed Older adults lack SARS CoV-2 cross-reactive T lymphocytes directed to human coronaviruses OC43 and NL63
title_sort older adults lack sars cov-2 cross-reactive t lymphocytes directed to human coronaviruses oc43 and nl63
publisher Nature Portfolio
publishDate 2020
url https://doaj.org/article/14096393e0f547299e16956eec9932db
work_keys_str_mv AT giuliettasaletti olderadultslacksarscov2crossreactivetlymphocytesdirectedtohumancoronavirusesoc43andnl63
AT thomasgerlach olderadultslacksarscov2crossreactivetlymphocytesdirectedtohumancoronavirusesoc43andnl63
AT janinamjansen olderadultslacksarscov2crossreactivetlymphocytesdirectedtohumancoronavirusesoc43andnl63
AT antoniamolle olderadultslacksarscov2crossreactivetlymphocytesdirectedtohumancoronavirusesoc43andnl63
AT husnielbahesh olderadultslacksarscov2crossreactivetlymphocytesdirectedtohumancoronavirusesoc43andnl63
AT martinludlow olderadultslacksarscov2crossreactivetlymphocytesdirectedtohumancoronavirusesoc43andnl63
AT wentaoli olderadultslacksarscov2crossreactivetlymphocytesdirectedtohumancoronavirusesoc43andnl63
AT berendjanbosch olderadultslacksarscov2crossreactivetlymphocytesdirectedtohumancoronavirusesoc43andnl63
AT albertdmeosterhaus olderadultslacksarscov2crossreactivetlymphocytesdirectedtohumancoronavirusesoc43andnl63
AT guusfrimmelzwaan olderadultslacksarscov2crossreactivetlymphocytesdirectedtohumancoronavirusesoc43andnl63
_version_ 1718384155349221376